Ethnic differences in primary angle-closure glaucoma.
暂无分享,去创建一个
[1] I. Lerman. Adherence to treatment: the key for avoiding long-term complications of diabetes. , 2005, Archives of medical research.
[2] H. Taylor,et al. The prevalence of glaucoma among Eskimos of northwest Alaska. , 1987, Archives of ophthalmology.
[3] M. Kass,et al. Compliance with topical pilocarpine treatment. , 1986, American journal of ophthalmology.
[4] Y. Frishberg,et al. Is Noncompliance Among Adolescent Renal Transplant Recipients Inevitable? , 2005, Pediatrics.
[5] M. Kass,et al. Compliance with topical timolol treatment. , 1987, American journal of ophthalmology.
[6] R K John,et al. Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. , 2000, Ophthalmology.
[7] L. Osterberg,et al. Adherence to medication. , 2005, The New England journal of medicine.
[8] A. Rotchford,et al. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. , 2003, Ophthalmology.
[9] Y. Yassur,et al. Epidemiology of acute angle-closure glaucoma: incidence and seasonal variations. , 1985, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[10] A. Reidy,et al. Prevalence of glaucoma in the west of Ireland. , 1993, The British journal of ophthalmology.
[11] Alsbirk Ph. Anatomical risk factors in primary angle-closure glaucoma. A ten year follow up survey based on limbal and axial anterior chamber depths in a high risk population. , 1992 .
[12] P. Alsbirk. ANTERIOR CHAMBER DEPTH IN GREENLAND ESKIMOS , 1974, Acta ophthalmologica.
[13] D. Friedman,et al. Ultrasonographic biomicroscopy, Scheimpflug photography, and novel provocative tests in contralateral eyes of Chinese patients initially seen with acute angle closure. , 2003, Archives of ophthalmology.
[14] N. Pfeiffer,et al. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[15] R. Pandey,et al. Ocular parameters in the subgroups of angle closure glaucoma , 2000, Clinical & experimental ophthalmology.
[16] P. Foster,et al. Can we prevent angle-closure glaucoma? , 2005, Eye.
[17] P. Foster,et al. Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays, and Indians in Singapore , 2000, The British journal of ophthalmology.
[18] M. Luntz. Primary angle-closure glaucoma in urbanized South African caucasoid and negroid communities. , 1973, The British journal of ophthalmology.
[19] E. MacLaughlin,et al. Assessing Medication Adherence in the Elderly , 2005, Drugs & aging.
[20] R. Parikh,et al. Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study , 2003, The British journal of ophthalmology.
[21] P. Alsbirk. ANTERIOR CHAMBER DEPTH IN GREENLAND ESKIMOS , 1974, Acta ophthalmologica.
[22] A. Fendrick,et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations , 2004, Journal of General Internal Medicine.
[23] C. McCarty,et al. Ocular biometry in occludable angles and angle closure glaucoma: a population based survey , 2003, The British journal of ophthalmology.
[24] G. Johnson,et al. The Burden of Trachoma in the Rural Nile Delta of Egypt : a Survey of Menofiya Governorate The Epidemiology of Ocular Trauma in Singapore : Perspective from the Emergency Service of a Large Tertiary Hospital , 2005 .
[25] M. Nurminen,et al. Incidence of acute glaucoma in Finland from 1973 to 1982 , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[26] N. Congdon,et al. Biometry and primary angle-closure glaucoma among Chinese, white, and black populations. , 1997, Ophthalmology.
[27] J. Tsai,et al. Current and emerging medical therapies for glaucoma , 2005, Expert opinion on emerging drugs.
[28] J. Lai,et al. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study. , 2001, Hong Kong medical journal = Xianggang yi xue za zhi.
[29] S. West,et al. Prevalence of glaucoma in a rural East African population. , 2000, Investigative ophthalmology & visual science.
[30] J. Pichert,et al. Situational Obstacles to Adherence for Adolescents with Diabetes , 1994, The Diabetes educator.
[31] G. Schwartz. Compliance and persistency in glaucoma follow-up treatment , 2005, Current opinion in ophthalmology.
[32] J. Avorn,et al. Treatment for glaucoma: adherence by the elderly. , 1993, American journal of public health.
[33] P. Foster,et al. Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. , 1997, Archives of ophthalmology.
[34] P. Foster,et al. Glaucoma in Mongolia. A population-based survey in Hövsgöl province, northern Mongolia. , 1996, Archives of ophthalmology.
[35] F. Camacho,et al. Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. , 2003, The American journal of geriatric pharmacotherapy.
[36] S. K. Seah,et al. Anterior chamber depth and the risk of primary angle closure in 2 East Asian populations. , 2005, Archives of ophthalmology.
[37] A. Iwase,et al. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. , 2005, Ophthalmology.
[38] M. C. Leske,et al. Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.
[39] S. Strakowski,et al. Factors associated with medication adherence in African American and white patients with bipolar disorder. , 2005, The Journal of clinical psychiatry.
[40] Qian-Li Xue,et al. Impaired Vision and the Ability to Take Medications , 2005, Journal of the American Geriatrics Society.
[41] Wanzhu Tu,et al. A conceptual framework to study medication adherence in older adults. , 2004, The American journal of geriatric pharmacotherapy.
[42] Robert Michael Richards,et al. Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes , 2004, The Annals of pharmacotherapy.
[43] M. Lowe. Primary Angle Closure Glaucoma: A Review of Ocular Biometry , 1977 .
[44] A. Paes,et al. Impact of Dosage Frequency on Patient Compliance , 1997, Diabetes Care.
[45] J. Schouten,et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. , 2005, Ophthalmology.
[46] D. Machin,et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. , 2000, Archives of ophthalmology.
[47] P. Foster,et al. The definition and classification of glaucoma in prevalence surveys , 2002, The British journal of ophthalmology.
[48] J. Urquhart. The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. , 2002, British journal of clinical pharmacology.
[49] R. Thomas,et al. Prevalence of primary glaucoma in an urban south Indian population. , 1998, Indian journal of ophthalmology.
[50] P. Hung,et al. Biometric study of acute primary angle-closure glaucoma. , 1997, Journal of the Formosan Medical Association = Taiwan yi zhi.
[51] J. Cramer,et al. A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.
[52] B. Guo,et al. Primary chronic angle-closure glaucoma in Chinese--a clinical exploration of its pathogenesis and natural course. , 1994, Yan ke xue bao = Eye science.
[53] N. Congdon,et al. Screening techniques for angle-closure glaucoma in rural Taiwan. , 2009, Acta ophthalmologica Scandinavica.
[54] N. Congdon,et al. Age, gender, biometry, refractive error, and the anterior chamber angle among Alaskan Eskimos. , 2003, Ophthalmology.
[55] T. Wagner,et al. Patient Strategies to Cope with High Prescription Medication Costs: Who is Cutting Back on Necessities, Increasing Debt, or Underusing Medications? , 2005, Journal of Behavioral Medicine.
[56] Eve A Kerr,et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. , 2005, Archives of internal medicine.
[57] R. Lowe. Causes of shallow anterior chamber in primary angle-closure glaucoma. Ultrasonic biometry of normal and angle-closure glaucoma eyes. , 1969, American journal of ophthalmology.
[58] Joseph Thomas,et al. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. , 2005, AIDS patient care and STDs.
[59] P. Muntner,et al. Methods to improve medication adherence in patients with hypertension: current status and future directions , 2005, Current opinion in cardiology.
[60] S. Resnikoff,et al. Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.
[61] R. Kaplan,et al. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. , 2004, Preventive medicine.
[62] H. Quigley. Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.
[63] H A Quigley,et al. THE NUMBER OF PERSONS WITH GLAUCOMA WORLDWIDE , 1996 .
[64] F. Hollows,et al. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. , 1966, The British journal of ophthalmology.
[65] P. Foster,et al. Anterior chamber depth in Mongolians: variation with age, sex, and method of measurement. , 1997, American journal of ophthalmology.
[66] G. Marchini,et al. Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. , 2000, Ophthalmology.
[67] A R Feinstein,et al. On white-coat effects and the electronic monitoring of compliance. , 1990, Archives of internal medicine.
[68] R. Dobson,et al. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. , 2005, The Canadian journal of cardiology.
[69] A. Rotchford,et al. Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. , 2002, Archives of ophthalmology.
[70] M. Ivanišević,et al. The incidence and seasonal variations of acute primary angle-closure glaucoma. , 2002, Collegium antropologicum.
[71] D G Schlundt,et al. Situational obstacles to dietary adherence for adults with diabetes. , 1994, Journal of the American Dietetic Association.
[72] Rajesh Balkrishnan,et al. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. , 2005, Medical care.
[73] A. Mermoud,et al. The prevalence of primary angle closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa. , 1993, Archives of ophthalmology.
[74] J. Erie,et al. The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota. , 1997, Archives of ophthalmology.
[75] Scott R. Smith,et al. Factors Influencing Medication Adherence Beliefs and Self-Efficacy in Persons Naive to Antiretroviral Therapy: A Multicenter, Cross-Sectional Study , 2004, AIDS and Behavior.
[76] S. Tsukahara,et al. Epidemiology of glaucoma in Japan--a nationwide glaucoma survey. , 1991, Japanese journal of ophthalmology.
[77] J. Zhao. [An epidemiological survey of primary angle-closure glaucoma (PACG) in Tibet]. , 1990, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.
[78] T. Wagner,et al. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? , 2004, Archives of internal medicine.
[79] D. Morrow,et al. Patient-centered instructions for medications prescribed for the treatment of heart failure. , 2004, The American journal of geriatric pharmacotherapy.
[80] J. Pichert,et al. Compliance Barriers in Glaucoma: A Systematic Classification , 2003, Journal of glaucoma.
[81] L. Cavalli-Sforza. Genes, peoples and languages. , 1991, Scientific American.
[82] Ravi Thomas,et al. Five-year risk of progression of primary angle closure to primary angle closure glaucoma: a population-based study. , 2003, Acta ophthalmologica Scandinavica.
[83] J Urquhart,et al. The Electronic Medication Event Monitor , 1997, Clinical pharmacokinetics.
[84] J. Cramer,et al. Compliance declines between clinic visits. , 1990, Archives of internal medicine.
[85] P. Alsbirk. Primary angle-closure glaucoma. Oculometry, epidemiology, and genetics in a high risk population. , 1976, Acta ophthalmologica. Supplementum.
[86] B. Meyers,et al. Effects of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. , 2005, Psychiatric services.
[87] N. Congdon,et al. Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. , 1992, Survey of ophthalmology.
[88] R. Bhopal. Is research into ethnicity and health racist, unsound, or important science? , 1997, BMJ.
[89] H. Taylor,et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. , 1998, Ophthalmology.
[90] P. Foster,et al. Biometric gonioscopy and the effects of age, race, and sex on the anterior chamber angle , 2002, The British journal of ophthalmology.
[91] A. Rotchford,et al. Compliance with timolol treatment in glaucoma , 1998, Eye.
[92] J. Jackson,et al. Perceived versus actual medication regimens among internal medicine patients. , 2004, Military medicine.
[93] Catherine Pope,et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. , 2005, Social science & medicine.
[94] A. Tomlinson,et al. Ocular dimensions in the heredity of angle-closure glaucoma. , 1973, The British journal of ophthalmology.
[95] A. Moscicki,et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. , 2003, Archives of pediatrics & adolescent medicine.